Latest filing published 04 Nov 2014 for Epizyme, Inc., €1,520.
Insider track record
No signal scores available.
Stephen Garbacz: trading record in brief
This profile gathers the share dealings of Stephen Garbacz in Epizyme, Inc. In total, 6 filings cover trades dated from 1 October 2014 to 3 November 2014.
Sales make up the whole of the open-market record (3 sales, €50k). Outside the open market, there are 3 option exercises.
Most recently, on 4 November 2014, the filings show an option exercise worth €1,520 in Epizyme, Inc. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Stephen Garbacz
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 868 shares@ US$2.19Common Stock, par value $0.0001 per shareSEC:0001209191-14-066385:0
- 868 shares@ US$26.44Common Stock, par value $0.0001 per shareSEC:0001209191-14-066385:1
- 535 shares@ US$3.54Common Stock, par value $0.0001 per shareSEC:0001209191-14-064930:0
- 535 shares@ US$30.00Common Stock, par value $0.0001 per shareSEC:0001209191-14-064930:1
- 868 shares@ US$2.19Common Stock, par value $0.0001 per shareSEC:0001209191-14-061882:0
- 868 shares@ US$27.06Common Stock, par value $0.0001 per shareSEC:0001209191-14-061882:1
6 of 6 declarations
